![Kaley Wilson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kaley Wilson
Director Ejecutivo en Sitka Biopharma, Inc. .
Perfil
Kaley Wilson is currently the Chief Executive Officer at Sitka Biopharma, Inc. and a Director at Microbion Corp., Quark Venture, Inc., and Crohn's & Colitis Canada.
Previously, he was the Chief Executive Officer at ARTMS, Inc. from 2018 to 2019.
He holds a doctorate degree from the University of British Columbia.
Cargos activos de Kaley Wilson
Empresas | Cargo | Inicio |
---|---|---|
Microbion Corp.
![]() Microbion Corp. Pharmaceuticals: MajorHealth Technology Microbion Corp. develops topical microbial therapeutic products. It safeguards human health by overcoming infections, antibiotic resistance, and microbial biofilms with safe, effective anti-infective products. The firm is developing MBN-101 as the first product in a new class for the treatment of antibiotic-resistant and difficult to treat infections. The company was founded by Brett H. Baker and is headquartered in Bozeman, MT. | Director/Miembro de la Junta | - |
Sitka Biopharma, Inc.
![]() Sitka Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Sitka Biopharma, Inc. develops novel polymer platform technology that improves drug absorption for cancer treatments. The company was founded by Michael Parr in 2013 and is headquartered in Vancouver, the United Kingdom. | Director Ejecutivo | - |
Quark Venture, Inc.
![]() Quark Venture, Inc. Investment ManagersFinance Quark Venture Inc (Quark) is a venture capital investment firm founded in 2015 and headquartered in Vancouver, Canada. | Inversor de Capital Privado | 01/10/2016 |
Crohn?s & Colitis Canada | Director/Miembro de la Junta | 01/05/2021 |
Antiguos cargos conocidos de Kaley Wilson.
Empresas | Cargo | Fin |
---|---|---|
ARTMS, Inc.
![]() ARTMS, Inc. BiotechnologyHealth Technology ARTMS, Inc. operates as biotechnology company, which develops novel technology and products. The company was founded by Michael Cross and is headquartered in Burnaby, Canada. | Director Ejecutivo | 10/09/2019 |
Formación de Kaley Wilson.
University of British Columbia | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 5 |
---|---|
Microbion Corp.
![]() Microbion Corp. Pharmaceuticals: MajorHealth Technology Microbion Corp. develops topical microbial therapeutic products. It safeguards human health by overcoming infections, antibiotic resistance, and microbial biofilms with safe, effective anti-infective products. The firm is developing MBN-101 as the first product in a new class for the treatment of antibiotic-resistant and difficult to treat infections. The company was founded by Brett H. Baker and is headquartered in Bozeman, MT. | Health Technology |
Quark Venture, Inc.
![]() Quark Venture, Inc. Investment ManagersFinance Quark Venture Inc (Quark) is a venture capital investment firm founded in 2015 and headquartered in Vancouver, Canada. | Finance |
Sitka Biopharma, Inc.
![]() Sitka Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Sitka Biopharma, Inc. develops novel polymer platform technology that improves drug absorption for cancer treatments. The company was founded by Michael Parr in 2013 and is headquartered in Vancouver, the United Kingdom. | Health Technology |
ARTMS, Inc.
![]() ARTMS, Inc. BiotechnologyHealth Technology ARTMS, Inc. operates as biotechnology company, which develops novel technology and products. The company was founded by Michael Cross and is headquartered in Burnaby, Canada. | Health Technology |
Crohn?s & Colitis Canada |
- Bolsa de valores
- Insiders
- Kaley Wilson